2013 Europe; New Product Innovation - Extremolyte Therapeutics for Allergies
2013 Europe; New Product Innovation - Extremolyte Therapeutics for Allergies
RELEASE DATE
07-May-2013
07-May-2013
REGION
Latin America
Latin America
Research Code: D979-00-4E-00-00
SKU: LS00088-LA-MR_16929
$1,500.00
In stock
SKU
LS00088-LA-MR_16929
This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients adherence to treatment by offering one weekly drug dose for managing the chronic disease. This deliverable includes information regarding market background, dynamics, challenges, trends, and access. The base year is 2013. Also, provided are a detailed analysis of products on the market and in development within Latin America, as well as clinical trial details and projected drugs launch timelines.
Popular Topics
This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients adherence to treatment by offering one weekly drug dose for managing the chronic disease. This deliverable includes information regarding market background, dynamics, challenges, trends, and access. The base year is 2013. Also, provided are a detailed analysis of products on the market and in development within Latin America, as well as clinical trial details and projected drugs launch timelines.
No Index | Yes |
---|---|
Podcast | No |
Author | Vin Nee Lim |
WIP Number | D979-00-4E-00-00 |
Is Prebook | No |